- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
By Geoff Sims for National Pain Report
As the medical marijuana rolls out in Florida (the 29th state to allow it), there is growing concern that the incoming Trump Administration—specifically Attorney General-designate Jeff Sessions—may try to roll its access back.
That’s why Americans for Safe Access says it has petitions with 70,000 signatures calling on the Drug Enforcement Administration to stop disseminating false information about medical cannabis immediately and ensure that any future information about medical cannabis treatment reflects medically-accurate and up-to-date facts.
The petition, which calls on President Obama to take immediate action, comes as the US Senate begins confirmation hearings for Senator Jeff Sessions’ (R-AL) appointment to Attorney General. Senator Sessions has actively opposed the use of medical and recreational cannabis saying, “good people don’t smoke marijuana” and argued that cannabis is a gateway drug that leads to cocaine and heroin use, something that has been resoundingly disproved by scientific evidence.
Here’s a link to the petition on Change.Org (click here)
Americans for Safe Access (ASA), a national nonprofit organization dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, has filed a legal request with the Department of Justice demanding that the DEA immediately update misinformation about cannabis. The request asks specifically for the clearing of misconceptions that cannabis is a gateway drug and causes irreversible cognitive decline in adults, psychosis, and lung cancer.
If granted, the filing could bring major changes to the way medical cannabis laws and regulations are treated by public officials. For decades, politicians have stated that now-disproven harmful effects were reasons to either prohibit or impose burdens on patients seeking safe and legal access to medical cannabis. While the DEA admitted in August that the gateway theory and other harmful claims are not supported by science, they have yet to remove all references of the disproven information, thereby continuing to spread inaccurate information.
“The DEA has actually admitted that cannabis is not a gateway drug and does not cause long-term brain damage, psychosis, and other alleged harms, yet they keep distributing this false information anyway, despite the reality these claims are not based on scientific fact,” said Beth Collins, Senior Director of Government Relations and External Affairs for Americans for Safe Access. “It’s illegal for the government to disseminate inaccurate information and the DEA must be held accountable. This misinformation hurts the millions of medical cannabis patients in the 29 states where cannabis treatment is legal, as well as patients in other states who are working to pass laws, for whom safe and reliable access to marijuana is a matter of necessity.”